Gustavo Alves Andrade dos Santos
The third pharmacological revolution marks an important stage in the evolutionary process of drugs used by humans. In less than a century, pharmacokinetic parameters and pharmacodynamic aspects have undergone important changes, providing increasingly effective therapeutic responses and a better margin of safety regarding the use of these drugs. Nano-drugs, biosimilars and monoclonal antibodies represent this moment of change and play a relevant role in the technological leap of the pharmaceutical industry. I highlight this transition period as an important milestone in the knowledge of pharmacology, therapeutics and medical practice, represented by the highly complex technological challenges to come.
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi